home / stock / spgi / spgi quote
Last: | $450.45 |
---|---|
Change Percent: | -0.01% |
Open: | $446.36 |
Close: | $450.45 |
High: | $450.77 |
Low: | $446.36 |
Volume: | 731,247 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$450.45 | $446.36 | $450.45 | $450.77 | $446.36 | 731,247 | 07-02-2024 |
$446.32 | $448.38 | $446.32 | $451.11 | $444.09 | 1,079,599 | 07-01-2024 |
$446 | $446.6 | $446 | $447.97 | $442.03 | 3,028,270 | 06-28-2024 |
$448.91 | $450 | $448.91 | $450.975 | $446.45 | 1,100,954 | 06-27-2024 |
$448.36 | $446.32 | $448.36 | $449.12 | $443.56 | 1,630,769 | 06-26-2024 |
$448.78 | $445.79 | $448.78 | $449.24 | $442.77 | 999,134 | 06-25-2024 |
$444.97 | $440.5 | $444.97 | $446.55 | $438.34 | 958,493 | 06-24-2024 |
$439.22 | $438.68 | $439.22 | $440.23 | $436 | 1,367,436 | 06-21-2024 |
$438.71 | $436.15 | $438.71 | $440.33 | $434.47 | 1,006,596 | 06-20-2024 |
$435.85 | $434.04 | $435.85 | $436.21 | $431.4 | 983,460 | 06-19-2024 |
$435.85 | $434.04 | $435.85 | $436.21 | $431.4 | 983,460 | 06-18-2024 |
$433.3 | $432.29 | $433.3 | $434.82 | $429.87 | 765,999 | 06-17-2024 |
$434.4 | $434.73 | $434.4 | $436 | $429.875 | 789,413 | 06-14-2024 |
$437.19 | $440 | $437.19 | $440.67 | $435.37 | 689,589 | 06-13-2024 |
$440.25 | $434.2 | $440.25 | $441.81 | $432.11 | 1,219,007 | 06-12-2024 |
$428.81 | $429.91 | $428.81 | $429.91 | $427.19 | 1,148,234 | 06-11-2024 |
$430 | $427.66 | $430 | $430.26 | $425.49 | 694,665 | 06-10-2024 |
$428.74 | $431.67 | $428.74 | $432.89 | $428.225 | 810,159 | 06-07-2024 |
$434.66 | $437.38 | $434.66 | $438.95 | $434.1 | 613,128 | 06-06-2024 |
$436.29 | $432.72 | $436.29 | $436.99 | $427.835 | 879,872 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 10:15:02 ET BMO Capital analyst issues OUTPERFORM recommendation for SPGI on July 2, 2024 08:38AM ET. The previous analyst recommendation was Outperform. SPGI was trading at $446.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
S&P Global Schedules Second Quarter 2024 Earnings Announcement and Conference Call for Tuesday, July 30, 2024 S&P Global Schedules Second Quarter 2024 Earnings Announcement and Conference Call for Tuesday, July 30, 2024 PR Newswire NEW YORK , June 28, 202...
Protagonist Therapeutics Set to Join S&P SmallCap 600 Protagonist Therapeutics Set to Join S&P SmallCap 600 PR Newswire NEW YORK , June 27, 2024 /PRNewswire/ -- Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in ...